153 related articles for article (PubMed ID: 6089937)
1. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects.
Rao AK; Willis J; Hassell B; Dangelmaier C; Holmsen H; Smith JB
Am J Hematol; 1984 Aug; 17(2):153-65. PubMed ID: 6431801
[TBL] [Abstract][Full Text] [Related]
3. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
[TBL] [Abstract][Full Text] [Related]
4. Impaired cytoplasmic ionized calcium mobilization in inherited platelet secretion defects.
Rao AK; Kowalska MA; Disa J
Blood; 1989 Aug; 74(2):664-72. PubMed ID: 2752141
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE
J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
[TBL] [Abstract][Full Text] [Related]
7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets.
Holmsen H; Daniel JL; Dangelmaier CA; Molish I; Rigmaiden M; Smith JB
Thromb Res; 1984 Dec; 36(5):419-28. PubMed ID: 6523448
[TBL] [Abstract][Full Text] [Related]
9. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
Rao AK; Poncz M
Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in the neonate.
Stuart MJ
Am J Pediatr Hematol Oncol; 1979; 1(3):227-34. PubMed ID: 543516
[TBL] [Abstract][Full Text] [Related]
13. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
14. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
[TBL] [Abstract][Full Text] [Related]
15. Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation.
Yang X; Sun L; Ghosh S; Rao AK
Blood; 1996 Sep; 88(5):1676-83. PubMed ID: 8781423
[TBL] [Abstract][Full Text] [Related]
16. Platelet secretion defect in patients with the attention deficit disorder and easy bruising.
Koike K; Rao AK; Holmsen H; Mueller PS
Blood; 1984 Feb; 63(2):427-33. PubMed ID: 6692042
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota.
Timmons S; Huzoor-Akbar ; Grabarek J; Kloczewiak M; Hawiger J
Blood; 1986 Nov; 68(5):1015-23. PubMed ID: 3768528
[TBL] [Abstract][Full Text] [Related]
18. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
19. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
[TBL] [Abstract][Full Text] [Related]
20. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
